Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Ronald E. Myers"'
Autor:
Hee Soon Juon, Marcella Pimpinelli, Brooke Ruane, Charnita Zeigler-Johnson, Russell K. McIntire, Christine S. Shusted, Julie A. Barta, Gregory C. Kane, Nathaniel R. Evans, Ronald E. Myers
Publikováno v:
Clinical Lung Cancer. 22:570-578
One challenge in high-quality lung cancer screening (LCS) is maintaining adherence with annual and short-interval follow-up screens among high-risk individuals who have undergone baseline low-dose CT (LDCT). This study aimed to characterize attitudes
Autor:
Chun Wang, Frederick M. Fellin, Darayus Toorkey, Kaelan Yao, Neha Pancholy, Saveri Bhattacharya, Maysa M. Abu-Khalaf, Ronald E. Myers, Rebecca Jaslow, Daniel P. Silver, Zhong Ye, AnaMaria Lopez, Hushan Yang, Zhenchao Zhang
Publikováno v:
Cancer Research. 80:P6-10
Background: Circulating tumor cells (CTCs) and their clusters (CTC-clusters) are promising prognostic markers in breast cancer. Recently studies showed that platelets interact with tumor cells in the circulation and promote metastasis. However, no st
Autor:
Chun Wang, Bingshan Li, Zhong Ye, Saveri Bhattacharya, Terrence P. Cescon, Hushan Yang, AnaMaria Lopez, Frederick M. Fellin, Maysa M. Abu-Khalaf, Daniel P. Silver, Ronald E. Myers, Qiang Wei, Zhenchao Zhang, Rebecca Jaslow
Publikováno v:
Cancer Research. 80:P4-10
Background: Palbociclib is the first-in-class cyclin dependent kinase (CDK) 4/6 inhibitor approved for the treatment of patients (pts) with hormone receptor (HR) positive/human epidermal growth factor receptor 2 (HER2) negative metastatic breast canc
Autor:
Sunmin Lee, Soomin Ryu, Carissa Kwan, Ronald E. Myers, Yuxi Shi, Luohua Jiang, Brittany N. Morey
Publikováno v:
Cancer Research. 82:CT164-CT164
Background: Colorectal cancer (CRC) is the second most common cancer among Asian Americans. However, cancer screening rates among Chinese- and Korean Americans are lower than other racial/ethnic groups in the United States. To address this disparity,
Autor:
Ronald E. Myers, Neha Pancholy, Xiaobing Chen, Zhenchao Zhang, Lifang Hou, Hushan Yang, Theodore N. Tsangaris, Chun Wang, Frederick M. Fellin, Zhaomei Mu, Jinliang Xing, Juan P. Palazzo, Manish Neupane, Daniel P. Silver, Qiang Wei, Rebecca Jaslow, Massimo Cristofanilli, Xiuhong Fu, Max Krall, Inna Chervoneva, Adam C. Berger, Saveri Bhattacharya, Shaogui Wan, Laura Austin, Darayus Toorkey, Maysa M. Abu-Khalaf, Zhong Ye, Xiuling Li, Bingshan Li, Kaelan Yao
Publikováno v:
European Journal of Cancer. 106:133-143
BACKGROUND: Both circulating tumor cell (CTC) and total circulating cell-free DNA (ccfDNA) predict cancer patient prognosis. However, no study has explored the prognostic value of the combined use of CTC and ccfDNA. We aimed to investigate individual
Autor:
Robert Pilarski, Arthur L. Burnett, Lucia R. Languino, Colette Hyatt, Jacqueline Powers, Robert B. Den, Alberto Briganti, Veda N. Giri, Lorelei A. Mucci, Daniel P. Petrylak, Oliver Sartor, Amie Blanco, Daniel W. Lin, Himisha Beltran, E. David Crawford, Karen E. Knudsen, Mary-Ellen Taplin, Brian T. Helfand, Felix Y. Feng, Costas D. Lallas, E. Michael D. Scott, Wayne H. Pinover, R. Jeffrey Karnes, Scott Weissman, Evan Y. Yu, Timothy R. Rebbeck, Ashley H. Woodson, Matthew J. Schiewer, Todd M. Morgan, William B. Isaacs, Jeffrey N. Weitzel, Alanna Kulchak Rahm, Michael S. Cookson, James A. Eastham, S. Bruce Malkowicz, Neha Vapiwala, Kevin R. Loughlin, Raoul S. Concepcion, Ana Maria Lopez, Jose Moreno, Brock O'Neil, Patrick T. Gomella, Patrick Mille, Charnita Zeigler-Johnson, Howard M. Sandler, Kathleen A. Cooney, William Tester, Sarah M. Nielsen, Thomas J. Polascik, Richard C. Wender, Howard R. Soule, Ronald E. Myers, Scott E. Eggener, Marc B. Garnick, Stacy Loeb, Martin Miner, Anthony J. Costello, Gerald L. Andriole, Amanda E. Toland, David Y.T. Chen, Albert Dobi, Joseph K Izes, Mary B. Daly, Leonard G. Gomella, Mark D. Hurwitz, J. Kellogg Parsons, Matthew L. Freedman, Nathan Handley, Adam P. Dicker, Jianfeng Xu, Michael Russell Mullane, Charles J. Ryan, Edouard J. Trabulsi, Anne Calvaresi, James Ryan Mark, Thenappan Chandrasekar, Colin C. Pritchard, Saud H. AlDubayan, Curtis A. Pettaway, William Kevin Kelly, Lindsey Byrne, Peter R. Carroll, Brittany M. Szymaniak, Alicia K. Morgans, Peter A. Pinto, William L. Dahut, Mark Mann, Ganesh V. Raj, James L. Mohler, Wendy Poage, Heather H. Cheng, Grace L. Lu-Yao
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol 38, iss 24
PURPOSE Germline testing (GT) is a central feature of prostate cancer (PCA) treatment, management, and hereditary cancer assessment. Critical needs include optimized multigene testing strategies that incorporate evolving genetic data, consistency in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1a0090e4e87cd120ef0899e6263c77c
https://escholarship.org/uc/item/3mg229rb
https://escholarship.org/uc/item/3mg229rb
Autor:
Daniel P. Silver, Weelic Chong, Geetha Jagannathan, Frederick M. Fellin, Kaelan Yao, Terrence P. Cescon, Maysa M. Abu-Khalaf, Chun Wang, Zhaomei Mu, Brian Lu, Manish Neupane, Ana Maria Lopez, Adam C. Berger, Rebecca Jaslow, Massimo Cristofanilli, Saveri Bhattacharya, Ronald E. Myers, Zhenchao Zhang, Qiang Wei, Bingshan Li, Zhong Ye, Theodore N. Tsangaris, Hushan Yang, Lifang Hou, Juan P. Palazzo
Publikováno v:
Breast Cancer Res Treat
PURPOSE: Discordance between HER2 expression in tumor tissue (tHER2) and HER2 status on circulating tumor cells (cHER2) has been reported. It remains largely underexplored whether patients with tHER2(−)/cHER2(+) can benefit from anti-HER2 targeted
Autor:
Ronald E. Myers, Terry Hyslop, Zhong Ye, Laura Austin, Jinliang Xing, Rebecca Jaslow, Juan P. Palazzo, Bingshan Li, Hushan Yang, Juntao Jiang, Jesse Civan, Massimo Cristofanilli, Chun Wang, Zhaomei Mu
Publikováno v:
Breast Cancer Research and Treatment. 154:563-571
The enumeration of circulating tumor cells (CTCs) provides important prognostic values in patients with metastatic breast cancer. Recent studies indicate that individual CTCs form clusters and these CTC-clusters play an important role in tumor metast
Autor:
Curtis A. Pettaway, Sarah M. Nielsen, Timothy R. Rebbeck, William Kevin Kelly, Robert B. Den, Neal D. Shore, Lawrence Karsh, Todd M. Morgan, Martin Miner, R. Jeffrey Karnes, Karen E. Knudsen, Christian P. Pavlovich, Edouard J. Trabulsi, Patrick C. Walsh, Eric A. Klein, Christopher J. Kane, Kevin R. Loughlin, Matthew L. Freedman, Richard C. Wender, Judd W. Moul, Grace L. Lu-Yao, Peter A. Pinto, Edward M. Schaeffer, David F. Penson, Mark Mann, Gordon F. Schwartz, Daniel P. Petrylak, James Ryan Mark, Carol J. Weil, Chris H. Bangma, William J. Catalona, Peter A. McCue, William B. Isaacs, Leonard G. Gomella, Wassim Abida, Jean H. Hoffman-Censits, Ganesh V. Raj, Mark D. Hurwitz, Colette Hyatt, David Crawford, S. Bruce Malkowicz, Robert G. Uzzo, Mark S. Shahin, Oliver Sartor, Wendy Poage, Daniel W. Lin, Scott A. Tomlins, Stephen C. Peiper, Amie Blanco, Neil Fleshner, Matthew R. Cooperberg, Elias Obeid, Kathleen A. Cooney, Ronald E. Myers, Scott E. Eggener, Robert Pilarski, Arthur L. Burnett, Matt T. Rosenberg, Veda N. Giri, Philip W. Kantoff, Gerald L. Andriole, Howard R. Soule, Donald J. Vander Griend, Adam P. Dicker, Justin E. Bekelman, Mitchell C. Benson, Freddie C. Hamdy, Howard M. Sandler, Mark E. Robson, Brian Shuch
Publikováno v:
Journal of Clinical Oncology, 36(4), 414-+. American Society of Clinical Oncology
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol 36, iss 4
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol 36, iss 4
Purpose Guidelines are limited for genetic testing for prostate cancer (PCA). The goal of this conference was to develop an expert consensus-driven working framework for comprehensive genetic evaluation of inherited PCA in the multigene testing era a
Autor:
Yinzhi Lai, Chun Wang, Zhaomei Mu, Massimo Cristofanilli, Jesse Civan, Ronald E. Myers, Laura Austin, Juan P. Palazzo, Zhong Ye, Hushan Yang
Publikováno v:
Breast Cancer Research and Treatment. 153:407-416
Current clinical guidelines state that the use of erythropoiesis-stimulating agents (ESAs) may be considered to treat chemotherapy-induced anemia in the non-curative setting to alleviate anemia-related symptoms. However, no convincing survival benefi